424 related articles for article (PubMed ID: 21345375)
21. Amyloid of Rnq1p, the basis of the [PIN+] prion, has a parallel in-register beta-sheet structure.
Wickner RB; Dyda F; Tycko R
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2403-8. PubMed ID: 18268327
[TBL] [Abstract][Full Text] [Related]
22. Yeast prions and human prion-like proteins: sequence features and prediction methods.
Cascarina SM; Ross ED
Cell Mol Life Sci; 2014 Jun; 71(11):2047-63. PubMed ID: 24390581
[TBL] [Abstract][Full Text] [Related]
23. [Yeast prions, mammalian amyloidoses, and the problem of proteomic networks].
Galkin AP; Mironova LN; Zhuravleva GA; Inge-Vechtomov SG
Genetika; 2006 Nov; 42(11):1558-70. PubMed ID: 17163073
[TBL] [Abstract][Full Text] [Related]
24. Primary sequence independence for prion formation.
Ross ED; Edskes HK; Terry MJ; Wickner RB
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12825-30. PubMed ID: 16123127
[TBL] [Abstract][Full Text] [Related]
25. Analysis of yeast prion aggregates with amyloid-staining compound in vivo.
Kimura Y; Koitabashi S; Fujita T
Cell Struct Funct; 2003 Jun; 28(3):187-93. PubMed ID: 12951439
[TBL] [Abstract][Full Text] [Related]
26. Structural insights into a yeast prion illuminate nucleation and strain diversity.
Krishnan R; Lindquist SL
Nature; 2005 Jun; 435(7043):765-72. PubMed ID: 15944694
[TBL] [Abstract][Full Text] [Related]
27. Yeast and Fungal Prions.
Wickner RB
Cold Spring Harb Perspect Biol; 2016 Sep; 8(9):. PubMed ID: 27481532
[TBL] [Abstract][Full Text] [Related]
28. Supporting the structural basis of prion strains: induction and identification of [PSI] variants.
King CY
J Mol Biol; 2001 Apr; 307(5):1247-60. PubMed ID: 11292339
[TBL] [Abstract][Full Text] [Related]
29. "Prion-proof" for [PIN+]: infection with in vitro-made amyloid aggregates of Rnq1p-(132-405) induces [PIN+].
Patel BK; Liebman SW
J Mol Biol; 2007 Jan; 365(3):773-82. PubMed ID: 17097676
[TBL] [Abstract][Full Text] [Related]
30. Prion and nonprion amyloids: a comparison inspired by the yeast Sup35 protein.
Kushnirov VV; Vishnevskaya AB; Alexandrov IM; Ter-Avanesyan MD
Prion; 2007; 1(3):179-84. PubMed ID: 19164899
[TBL] [Abstract][Full Text] [Related]
31. Generation of prion transmission barriers by mutational control of amyloid conformations.
Chien P; DePace AH; Collins SR; Weissman JS
Nature; 2003 Aug; 424(6951):948-51. PubMed ID: 12931190
[TBL] [Abstract][Full Text] [Related]
32. Prions of yeast are genes made of protein: amyloids and enzymes.
Wickner RB; Edskes HK; Ross ED; Pierce MM; Shewmaker F; Baxa U; Brachmann A
Cold Spring Harb Symp Quant Biol; 2004; 69():489-96. PubMed ID: 16117685
[No Abstract] [Full Text] [Related]
33. Innate immunity to prions: anti-prion systems turn a tsunami of prions into a slow drip.
Wickner RB; Edskes HK; Son M; Wu S; Niznikiewicz M
Curr Genet; 2021 Dec; 67(6):833-847. PubMed ID: 34319422
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of cross-species prion transmission: an infectious conformation compatible with two highly divergent yeast prion proteins.
Tanaka M; Chien P; Yonekura K; Weissman JS
Cell; 2005 Apr; 121(1):49-62. PubMed ID: 15820678
[TBL] [Abstract][Full Text] [Related]
35. Prions.
Shkundina IS; Ter-Avanesyan MD
Biochemistry (Mosc); 2007 Dec; 72(13):1519-36. PubMed ID: 18282140
[TBL] [Abstract][Full Text] [Related]
36. Prion stability.
Cox BS; Byrne LJ; Tuite MF
Prion; 2007; 1(3):170-8. PubMed ID: 19164897
[TBL] [Abstract][Full Text] [Related]
37. The protein-only theory and the yeast Saccharomyces cerevisiae: the prions and the propagons.
Fernandez-Bellot E; Cullin C
Cell Mol Life Sci; 2001 Nov; 58(12-13):1857-78. PubMed ID: 11766884
[TBL] [Abstract][Full Text] [Related]
38. Amyloid diseases of yeast: prions are proteins acting as genes.
Wickner RB; Edskes HK; Bateman DA; Kelly AC; Gorkovskiy A; Dayani Y; Zhou A
Essays Biochem; 2014; 56():193-205. PubMed ID: 25131596
[TBL] [Abstract][Full Text] [Related]
39. A new colour assay for [URE3] prion in a genetic background used to score for the [PSI⁺] prion.
Hong JY; Mathur V; Liebman SW
Yeast; 2011 Jul; 28(7):555-60. PubMed ID: 21590810
[TBL] [Abstract][Full Text] [Related]
40. The physical dimensions of amyloid aggregates control their infective potential as prion particles.
Marchante R; Beal DM; Koloteva-Levine N; Purton TJ; Tuite MF; Xue WF
Elife; 2017 Sep; 6():. PubMed ID: 28880146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
